Invivyd, Inc. is a microcap biotech company focusing on antibody-based treatments for infectious diseases like COVID-19.
Hosted on MSN3d
This Penny Stock Just Doubled on Clinical Trial Results. Analysts Think It Can Surge 266% From Here.Biotechnology is a high-risk, high-reward landscape where innovation determines success. Yet, occasionally, a small player ...
Invivyd has teamed up with professional football coach Jim Harbaugh to tackle COVID-19 complacency. The biotech, which has ...
We recently compiled a list of the Why These 15 Healthcare Stocks Are Skyrocketing So Far In 2025. In this article, we are ...
Invivyd, Inc. (NASDAQ:IVVD – Get Free Report) was the recipient of unusually large options trading on Thursday. Traders ...
PEMGARDA™ (pemivibart) net product revenue of $13.8 million, 48% growth over Q3 2024 net product revenue of $9.3 ...
Invivyd data shows strong potency and prolonged antibody levels in trials. Q4 Pemgarda revenue rose 48% to $13.8 million.
Teaming up to raise awareness of the continuing toll of COVID-19 in America, an ongoing mass disabling event causing an American death ...
Invivyd, Inc. has announced a partnership with football coach Jim Harbaugh to raise awareness about the ongoing impacts of COVID-19, which continues to be a significant health crisis in America ...
Harbaugh teamed up with Invivyd to encourage people to learn more about the symptoms of long COVID. Los Angeles Chargers head ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback